TY - JOUR
T1 - Knowledge and attitude of hereditary breast cancer among Japanese university female students
AU - Terui-Kohbata, Hiroko
AU - Egawa, Makiko
AU - Yura, Kei
AU - Yoshida, Masayuki
N1 - Funding Information:
Acknowledgements This survey was supported by Tokyo Interdisciplinary Life Science Consortium. We appreciate Ms Mariko Nakagawa for helping data processing. This research was supported by JSPS KAKENHI Grant number JP17K17689.
Publisher Copyright:
© 2020, The Author(s), under exclusive licence to The Japan Society of Human Genetics.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - BRCA1/2 genetic testing to use PARP inhibitor for breast cancer has a possibility of the “secondary finding” among the younger nonaffected family members of the patient, which turns them into at-risk for hereditary breast cancer. Proper understanding of the background of the hereditary cancer is now required for appropriate acceptance of the risk. Therefore, we investigated the level of knowledge and attitudes of younger women on hereditary breast cancer in Japan. Study subject was Japanese university women between 20 and 30 years of age, without medical history of breast cancer. We conducted the anonymous self-answering questionnaire to them. We received responses from 353 women. The levels of knowledge, awareness, and interest were relatively high. Women with a family history of breast cancer were less likely to undergo testing than women without (92.8% vs. 74.5%, p < 0.001). The rates of positive response toward risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) was significantly high for medical majors compared with that for other majors (RRM: medical 71.6% vs. science 54.5% vs. humanities 53.8%, p = 0.008, RRSO: 35.4% vs. 36.3% vs. 48.4%, p = 0.027). Approximately half of respondents answered that they would hesitate to get married (45.3%) or to have children (55.4%), if they were a BRCA1/2 mutation carrier. The results may help to establish the methods for supporting the decision-making for reproduction of younger women who are unexpectedly labeled as being at-risk for HBOC.
AB - BRCA1/2 genetic testing to use PARP inhibitor for breast cancer has a possibility of the “secondary finding” among the younger nonaffected family members of the patient, which turns them into at-risk for hereditary breast cancer. Proper understanding of the background of the hereditary cancer is now required for appropriate acceptance of the risk. Therefore, we investigated the level of knowledge and attitudes of younger women on hereditary breast cancer in Japan. Study subject was Japanese university women between 20 and 30 years of age, without medical history of breast cancer. We conducted the anonymous self-answering questionnaire to them. We received responses from 353 women. The levels of knowledge, awareness, and interest were relatively high. Women with a family history of breast cancer were less likely to undergo testing than women without (92.8% vs. 74.5%, p < 0.001). The rates of positive response toward risk-reducing mastectomy (RRM) and risk-reducing salpingo-oophorectomy (RRSO) was significantly high for medical majors compared with that for other majors (RRM: medical 71.6% vs. science 54.5% vs. humanities 53.8%, p = 0.008, RRSO: 35.4% vs. 36.3% vs. 48.4%, p = 0.027). Approximately half of respondents answered that they would hesitate to get married (45.3%) or to have children (55.4%), if they were a BRCA1/2 mutation carrier. The results may help to establish the methods for supporting the decision-making for reproduction of younger women who are unexpectedly labeled as being at-risk for HBOC.
UR - http://www.scopus.com/inward/record.url?scp=85082817096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082817096&partnerID=8YFLogxK
U2 - 10.1038/s10038-020-0743-9
DO - 10.1038/s10038-020-0743-9
M3 - Article
C2 - 32203254
AN - SCOPUS:85082817096
SN - 1434-5161
VL - 65
SP - 591
EP - 599
JO - Jinrui idengaku zasshi. The Japanese journal of human genetics
JF - Jinrui idengaku zasshi. The Japanese journal of human genetics
IS - 7
ER -